ITRI.NASDAQItron, INC

Form 4: Director Sanjay Mirchandani Receives Itron Stock Grant

Sentiment:

Statement of Changes in Beneficial Ownership


Itron, Inc. director Sanjay Mirchandani acquired 580 shares of common stock as part of his quarterly board compensation.

Summary

  • Director Sanjay Mirchandani was granted 580 shares of Itron, Inc. (ITRI) common stock on April 1, 2026.
  • The shares were issued as part of the standard quarterly compensation package for independent members of the board of directors.
  • Following this transaction, the reporting person holds a total of 6,203 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation with no impact on company operations or financial strategy.

Positives

  • The transaction reflects standard equity-based compensation for board members, aligning director interests with long-term shareholder value.

Negatives

  • None.

Risks

  • None.

Future Outlook

Not applicable as this is a routine disclosure of director compensation.

Management Comments

  • The grant reflects the quarterly compensation independent members of Itron's board of directors receive for their service.

Industry Context

StockSavvy.ai notes that routine equity grants to board members are standard corporate governance practices in the technology and utility infrastructure sectors, serving to ensure director alignment with company performance.

Comparison to Industry Standards

  • The issuance of equity as part of director compensation is consistent with standard practices for S&P 400 and similar mid-cap companies.
  • The transaction size is immaterial relative to the total outstanding shares of Itron, Inc.

Stakeholder Impact

  • No material impact on shareholders, employees, or creditors.

Next Steps

  • None.

Key Dates

DateDescription
04/01/2026Date of the stock grant transaction.
04/02/2026Date of filing the Form 4.

Keywords

Itron, ITRI, Form 4, Insider Trading, Director Compensation, Equity Grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.